In episode 11 of the Ori Spotlight Podcast we sit down with Paul Meister, Partner at Novalis LifeSciences - lead investor of Ori Biotech’s series B round - as he shares his perspectives on the potential for CGT.
Paul has extensive experience across the pharmaceutical, biotech and life science fields, having orchestrated the merger of Thermo Electron and Fisher Scientific before becoming chair of Thermo Fisher and, later, chair and CEO of Syneos Health. In this episode, he catches up with Jason C. Foster following the closure of Ori’s $101 million series B round, to explain why he decided to join us on our mission to enable widespread patient access to CGTs and what excites him most about our partnership.
